WEDNESDAY, April 4, 2018 — Testicular cancer survivors (TCS) have metabolic abnormalities characterized by hypertension and increased low-density lipoprotein (LDL) and total cholesterol, according to a study published in the March 1 issue of the Journal of the National Comprehensive Cancer Network.
Mohammad Abu Zaid, M.D., from Indiana University in Indianapolis, and colleagues examined clinical and genetic metabolic syndrome (MetS) risk factors in 486 North American TCS aged <55 years at diagnosis and who received first-line chemotherapy.
The researchers found that, compared with controls, TCS had a higher prevalence of hypertension (43.2 versus 30.7 percent; P < 0.001), but they were less likely to have decreased high-density lipoprotein (HDL) cholesterol levels (23.7 versus 34.8 percent; P < 0.001) or abdominal obesity (28.2 versus 40.1 percent; P < 0.001). The frequency of MetS was similar in TCS and controls (21.0 versus 22.4 percent; P = 0.59), with no difference by treatment (P = 0.20) and no correlation with rs523349 (5-α-reductase gene SRD5A2; P = 0.61). TCS were significantly more likely to have increased LDL cholesterol levels (P < 0.001), total cholesterol levels (P < 0.001), and body mass index ≥25 kg/m² (P = 0.04). There were significant associations for age at evaluation, testosterone level ≤3.0 ng/mL, and elevated soluble cell adhesion molecule-1 level with MetS.
“Metabolic abnormalities in TCS are characterized by hypertension and increased LDL and total cholesterol levels but lower rates of decreased HDL levels and abdominal obesity, signifying possible shifts in fat distribution and fat metabolism,” the authors write.
© 2018 HealthDay. All rights reserved.
Posted: April 2018
- Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
- At colloquium, a range of views on value of predictive algorithms | News Center
- Pittcon invites oral and poster presentations for 2019 Technical Program
- Virtual reality could offer psychotherapy for fear of heights, study shows
- Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
- Kolon TissueGene To Start US Phase III Clinical Trial For Invossa
- Study finds prenatal marijuana use can affect infant size, behavior
- Howard Chang named HHMI investigator | News Center
- Study shows tailored mental health services improve wellbeing of emerging adults
- A bright future might help teens steer clear of violence
- Stanford Medicine magazine explores the art, science of listening and hearing | News Center
- New study tracks how the brain turns simple sensory inputs into meaningful categories
- Deadlier subtype of metastatic prostate cancer found to be common than previously thought
- UZH scientists identify enzyme that controls cell division
- Unhealthy Food Behaviors May Signal Eating Disorder in Teen
- Study raises doubts on a previous theory of Parkinson’s disease
- Grant awarded to study whether stem cells can treat urinary incontinence | News Center
- Imaging techniques may help assess immune system recovery in HIV patients
- Machine-learning may aid in diagnosis and treatment of mental health disorders
- ‘Skin Cancer, Take A Hike!’ program promotes sun safety and skin cancer awareness